Analyst Ratings For NASDAQ:CTXR – Citius Pharmaceuticals (NASDAQ:CTXR)
Today, HC Wainwright initiated coverage on NASDAQ:CTXR – Citius Pharmaceuticals (NASDAQ:CTXR) with a Buy with a price target of $11.00.
Some recent analyst ratings include
- 5/23/2018-HC Wainwright initiated coverage with a Buy rating.
- On 3/28/2018 Myron Z Holubiak, Insider, bought 2,915 with an average share price of $3.09 per share and the total transaction amounting to $9,007.35.
- On 8/24/2017 Leonard L Mazur, Insider, bought 11,000 with an average share price of $2.68 per share and the total transaction amounting to $29,480.00.
- On 8/8/2017 Leonard L Mazur, Insider, bought 421,400 with an average share price of $4.13 per share and the total transaction amounting to $1,740,382.00.
Recent Trading Activity for NASDAQ:CTXR – Citius Pharmaceuticals (NASDAQ:CTXR)
Shares of NASDAQ:CTXR – Citius Pharmaceuticals closed the previous trading session at 2.70 up +0.25 10.20% with shares trading hands.